MX2019002541A - Derivados de pirimidina contra virus de la influenza. - Google Patents

Derivados de pirimidina contra virus de la influenza.

Info

Publication number
MX2019002541A
MX2019002541A MX2019002541A MX2019002541A MX2019002541A MX 2019002541 A MX2019002541 A MX 2019002541A MX 2019002541 A MX2019002541 A MX 2019002541A MX 2019002541 A MX2019002541 A MX 2019002541A MX 2019002541 A MX2019002541 A MX 2019002541A
Authority
MX
Mexico
Prior art keywords
influenza virus
pyrimidine derivative
virus pyrimidine
compounds
disclosed
Prior art date
Application number
MX2019002541A
Other languages
English (en)
Inventor
Wang Jingjing
Li Peng
Chen Xiaoxin
Chen Shuhui
Long Chaofeng
Li Jian
Xiong Jian
X Chen Kevin
Xie Cheng
Peng Xuanjia
Original Assignee
Guangdong Raynovent Biotech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangdong Raynovent Biotech Co Ltd filed Critical Guangdong Raynovent Biotech Co Ltd
Publication of MX2019002541A publication Critical patent/MX2019002541A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente invención publica los compuestos contra el virus de la influenza de clase I, así como su aplicación en la preparación y el tratamiento con los fármacos relacionados con el virus de la influenza. Los compuestos mostrados en la fórmula (I) y sus sales farmacéuticamente aceptables están específicamente publicados. Ver fórmula I.
MX2019002541A 2016-09-05 2017-09-05 Derivados de pirimidina contra virus de la influenza. MX2019002541A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201610804101 2016-09-05
CN201611238759 2016-12-28
PCT/CN2017/100461 WO2018041263A1 (zh) 2016-09-05 2017-09-05 抗流感病毒嘧啶衍生物

Publications (1)

Publication Number Publication Date
MX2019002541A true MX2019002541A (es) 2019-07-01

Family

ID=61300177

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019002541A MX2019002541A (es) 2016-09-05 2017-09-05 Derivados de pirimidina contra virus de la influenza.

Country Status (14)

Country Link
US (3) US11136319B2 (es)
EP (1) EP3502112A4 (es)
JP (1) JP6838773B2 (es)
KR (1) KR102312088B1 (es)
CN (3) CN109790159B (es)
AU (1) AU2017320088B2 (es)
BR (1) BR112019004420A2 (es)
CA (1) CA3035680C (es)
IL (1) IL265166B (es)
MX (1) MX2019002541A (es)
RU (1) RU2727772C1 (es)
SG (1) SG11201901894TA (es)
WO (1) WO2018041263A1 (es)
ZA (1) ZA201901886B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107759571B (zh) 2016-08-16 2021-03-02 广东东阳光药业有限公司 流感病毒复制抑制剂及其使用方法和用途
WO2018041091A1 (en) 2016-08-30 2018-03-08 Sunshine Lake Pharma Co., Ltd. Inhibitors of influenza virus replication, application methods and uses thereof
CN109790159B (zh) * 2016-09-05 2020-01-14 广东众生睿创生物科技有限公司 抗流感病毒嘧啶衍生物
WO2018108125A1 (en) 2016-12-15 2018-06-21 Sunshine Lake Pharma Co., Ltd. Inhibitors of influenza virus replication and uses thereof
US11098042B2 (en) 2017-01-05 2021-08-24 Sunshine Lake Pharma Co., Ltd. Inhibitors of influenza virus replication and uses thereof
CN110446711B (zh) 2017-03-02 2022-02-15 广东东阳光药业有限公司 流感病毒复制抑制剂及其用途
AU2019230497B2 (en) * 2018-03-05 2021-08-05 Guangdong Raynovent Biotech Co., Ltd. Crystal form and salt form of pyridoimidazole compound and preparation method therefor
CN110590768B (zh) * 2018-06-13 2021-02-26 银杏树药业(苏州)有限公司 杂环化合物、其组合物及其作为抗流感病毒药物的应用
EP3992192A4 (en) * 2019-07-22 2022-08-17 Guangdong Raynovent Biotech Co., Ltd. DOMINANT SALT FORMS OF PYRIMIDINE DERIVATIVES AND CRYSTAL FORMS THEREOF
CN114502150B (zh) * 2019-09-10 2023-03-24 广东众生睿创生物科技有限公司 一种用于治疗病毒性感冒的药物组合物及其制剂
CN111454166B (zh) * 2019-12-30 2021-02-26 广东莱佛士制药技术有限公司 制备(2s,3s)-3-氨基-二环[2.2.2]辛烷-2-甲酸酯的方法
CN113116899B (zh) * 2020-03-06 2022-12-20 广东众生睿创生物科技有限公司 一种用于治疗流感的药物组合物及含有该药物组合物的制剂
CN116323593A (zh) * 2020-10-29 2023-06-23 广东众生睿创生物科技有限公司 一种嘧啶衍生物的晶型及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3141252B8 (en) * 2009-06-17 2019-03-13 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
CN103492381A (zh) * 2010-12-16 2014-01-01 沃泰克斯药物股份有限公司 流感病毒复制的抑制剂
US20130102600A1 (en) * 2011-10-21 2013-04-25 F. Hoffmann-La Roche Ltd Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease
MX2017001752A (es) * 2014-08-08 2018-02-08 Janssen Sciences Ireland Uc Indoles para su uso en la infección por el virus de la gripe.
CA3005921A1 (en) * 2015-12-09 2017-06-15 Sunshine Lake Pharma Co., Ltd. Substituted-(pyrrolo[2,3-b]pyridin-3-yl)-pyrimidin derivatives and use thereof as inhibitors of influenza virus replication
WO2017133657A1 (en) * 2016-02-05 2017-08-10 Savira Pharmaceuticals Gmbh Pyridine and pyrimidine derivatives and their use in treatment, amelioration or prevention of influenza
WO2017133670A1 (en) 2016-02-05 2017-08-10 Savira Pharmaceuticals Gmbh Pyridine and pyrimidine derivatives and their use in treatment, amelioration or prevention of influenza
CN107759571B (zh) * 2016-08-16 2021-03-02 广东东阳光药业有限公司 流感病毒复制抑制剂及其使用方法和用途
CN109790159B (zh) * 2016-09-05 2020-01-14 广东众生睿创生物科技有限公司 抗流感病毒嘧啶衍生物
AU2019230497B2 (en) * 2018-03-05 2021-08-05 Guangdong Raynovent Biotech Co., Ltd. Crystal form and salt form of pyridoimidazole compound and preparation method therefor

Also Published As

Publication number Publication date
US11725009B2 (en) 2023-08-15
AU2017320088B2 (en) 2020-01-30
CN110627784B (zh) 2021-09-21
AU2017320088A1 (en) 2019-04-18
US20220135558A1 (en) 2022-05-05
CN110623958B (zh) 2022-05-17
EP3502112A1 (en) 2019-06-26
US11136319B2 (en) 2021-10-05
NZ751964A (en) 2021-02-26
KR102312088B1 (ko) 2021-10-14
IL265166B (en) 2021-09-30
KR20190056380A (ko) 2019-05-24
US20210032238A1 (en) 2021-02-04
CA3035680A1 (en) 2018-03-08
BR112019004420A2 (pt) 2019-05-28
CN110627784A (zh) 2019-12-31
SG11201901894TA (en) 2019-04-29
US20230339943A1 (en) 2023-10-26
CN109790159A (zh) 2019-05-21
RU2727772C1 (ru) 2020-07-23
CA3035680C (en) 2023-05-02
WO2018041263A1 (zh) 2018-03-08
JP2019529386A (ja) 2019-10-17
CN109790159B (zh) 2020-01-14
EP3502112A4 (en) 2019-06-26
CN110623958A (zh) 2019-12-31
IL265166A (en) 2019-05-30
JP6838773B2 (ja) 2021-03-03
ZA201901886B (en) 2021-01-27

Similar Documents

Publication Publication Date Title
MX2019002541A (es) Derivados de pirimidina contra virus de la influenza.
MX2021007432A (es) Compuestos y composiciones para inhibir la actividad de shp2.
PH12018550120A1 (en) Steroid derivative fxr agonist
CY1119490T1 (el) Παραγωγα πυραζολοπυρρολιδινης και η χρηση τους στην θεραπεια νοσηματων
MX2022009352A (es) Sal de hemisulfato de nucleotido para el tratamiento del virus de hepatitis c.
NZ732391A (en) Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
MY196243A (en) Dihydropyrimidine Compounds and Their Application In Pharmaceuticals
TW201613593A (en) Molecules for administration to ROS1 mutant cancer cells
MD20150092A2 (ro) Derivate ale amidelor pentru tratamentul infecţiei cu HIV
NZ631726A (en) Therapeutic compounds for the treatment of viral infections
EA201892219A1 (ru) Замещенные производные индолина в качестве ингибиторов репликации вирусов денге
EA201892216A1 (ru) Замещенные производные индолина в качестве ингибиторов репликации вирусов денге
MX368903B (es) Compuestos terapéuticos y sus usos en el tratamiento de enfermedades proliferativas.
AU2015211852A1 (en) Heterocyclic sulfonamide derivative and medicine comprising same
PH12019501955A1 (en) Tri-cycle compound and applications thereof
SA520411635B1 (ar) A2a مشتق حلقي مدمج كمثبط مستقبل
EA201692298A1 (ru) Производные карбоксамидов
PH12016502246B1 (en) Carboxamide derivatives
PH12016502243A1 (en) Pharmaceutical compositions for treating infectious diseases
CL2015003431A1 (es) Derivados de piridona para el tratamiento de infecciones virales y enfermedades adicionales
EA201790632A1 (ru) 4'-винилзамещенные производные нуклеозидов в качестве ингибиторов репликации рнк респираторно-синцитиального вируса
EA201890788A1 (ru) Препараты оланзапина с замедленным высвобождением
EA201990834A1 (ru) Пиримидиновые пролекарства для лечения вирусных инфекций и других заболеваний
EA038580B9 (ru) Агонист fxr, представляющий собой производное стероидов
NZ724063A (en) Pyrazine derivatives having pharmaceutical activity